HOP-flash Citations (20)
Originally described in: Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway.Kim NG, Gumbiner BM J Cell Biol. 2015 Aug 3;210(3):503-15. doi: 10.1083/jcb.201501025. Epub 2015 Jul 27. PubMed Journal
Articles Citing HOP-flash
Articles |
---|
Downregulation of miR-874-3p promotes chemotherapeutic resistance in colorectal cancer via inactivation of the Hippo signaling pathway. Que K, Tong Y, Que G, Li L, Lin H, Huang S, Wang R, Tang L. Oncol Rep. 2017 Dec;38(6):3376-3386. doi: 10.3892/or.2017.6041. Epub 2017 Oct 17. PubMed |
miR1495p promotes chemotherapeutic resistance in ovarian cancer via the inactivation of the Hippo signaling pathway. Xu M, Xiao J, Chen M, Yuan L, Li J, Shen H, Yao S. Int J Oncol. 2018 Mar;52(3):815-827. doi: 10.3892/ijo.2018.4252. Epub 2018 Jan 24. PubMed |
Dishevelled has a YAP nuclear export function in a tumor suppressor context-dependent manner. Lee Y, Kim NH, Cho ES, Yang JH, Cha YH, Kang HE, Yun JS, Cho SB, Lee SH, Paclikova P, Radaszkiewicz TW, Bryja V, Kang CG, Yuk YS, Cha SY, Kim SY, Kim HS, Yook JI. Nat Commun. 2018 Jun 12;9(1):2301. doi: 10.1038/s41467-018-04757-w. PubMed |
ZNF280A Promotes Proliferation and Tumorigenicity via Inactivating the Hippo-Signaling Pathway in Colorectal Cancer. Wang X, Sun D, Tai J, Chen S, Hong S, Wang L. Mol Ther Oncolytics. 2019 Jan 25;12:204-213. doi: 10.1016/j.omto.2019.01.002. eCollection 2019 Mar 29. PubMed |
Blockade of leukemia inhibitory factor as a therapeutic approach to KRAS driven pancreatic cancer. Wang MT, Fer N, Galeas J, Collisson EA, Kim SE, Sharib J, McCormick F. Nat Commun. 2019 Jul 11;10(1):3055. doi: 10.1038/s41467-019-11044-9. PubMed |
miR-424-5p Promotes Anoikis Resistance and Lung Metastasis by Inactivating Hippo Signaling in Thyroid Cancer. Liu X, Fu Y, Zhang G, Zhang D, Liang N, Li F, Li C, Sui C, Jiang J, Lu H, Zhao Z, Dionigi G, Sun H. Mol Ther Oncolytics. 2019 Nov 13;15:248-260. doi: 10.1016/j.omto.2019.10.008. eCollection 2019 Dec 20. PubMed |
Metabolic Reprogramming Promotes Neural Crest Migration via Yap/Tead Signaling. Bhattacharya D, Azambuja AP, Simoes-Costa M. Dev Cell. 2020 Apr 20;53(2):199-211.e6. doi: 10.1016/j.devcel.2020.03.005. Epub 2020 Apr 2. PubMed |
lncRNA USP2-AS1 promotes colon cancer progression by modulating Hippo/YAP1 signaling. Li D, Bao J, Yao J, Li J. Am J Transl Res. 2020 Sep 15;12(9):5670-5682. eCollection 2020. PubMed |
FLNC Expression Level Influences the Activity of TEAD-YAP/TAZ Signaling. Knyazeva A, Khudiakov A, Vaz R, Muravyev A, Sukhareva K, Sejersen T, Kostareva A. Genes (Basel). 2020 Nov 13;11(11). pii: genes11111343. doi: 10.3390/genes11111343. PubMed |
PIN1 facilitates ubiquitin-mediated degradation of serine/threonine kinase 3 and promotes melanoma development via TAZ activation. Kim G, Bhattarai PY, Lim SC, Kim JY, Choi HS. Cancer Lett. 2021 Feb 28;499:164-174. doi: 10.1016/j.canlet.2020.11.033. Epub 2020 Nov 27. PubMed |
Silencing SAPCD2 Represses Proliferation and Lung Metastasis of Fibrosarcoma by Activating Hippo Signaling Pathway. Zhu B, Wu Y, Niu L, Yao W, Xue M, Wang H, Yang J, Li J, Fan W. Front Oncol. 2020 Dec 15;10:574383. doi: 10.3389/fonc.2020.574383. eCollection 2020. PubMed |
Long Non-Coding RNA MAPK8IP1P2 Inhibits Lymphatic Metastasis of Thyroid Cancer by Activating Hippo Signaling via Sponging miR-146b-3p. Liu X, Fu Q, Bian X, Fu Y, Xin J, Liang N, Li S, Zhao Y, Fang L, Li C, Zhang J, Dionigi G, Sun H. Front Oncol. 2021 Jan 7;10:600927. doi: 10.3389/fonc.2020.600927. eCollection 2020. PubMed |
TAZ exhibits phase separation properties and interacts with Smad7 and beta-catenin to repress skeletal myogenesis. Tripathi S, Miyake T, Kelebeev J, McDermott JC. J Cell Sci. 2022 Jan 1;135(1). pii: 273968. doi: 10.1242/jcs.259097. Epub 2022 Jan 12. PubMed |
YAP Transcriptional Activity Dictates Cell Response to TNF In Vitro. Caire R, Dalix E, Chafchafi M, Thomas M, Linossier MT, Normand M, Guignandon A, Vico L, Marotte H. Front Immunol. 2022 Mar 23;13:856247. doi: 10.3389/fimmu.2022.856247. eCollection 2022. PubMed |
Drug repositioning of polaprezinc for bone fracture healing. Ko EA, Park YJ, Yoon DS, Lee KM, Kim J, Jung S, Lee JW, Park KH. Commun Biol. 2022 May 16;5(1):462. doi: 10.1038/s42003-022-03424-7. PubMed |
De novo pyrimidine synthesis fuels glycolysis and confers chemoresistance in gastric cancer. He D, Chen M, Chang L, Gu J, Liu F, Gao X, Ruan Y. Cancer Lett. 2022 Nov 28;549:215837. doi: 10.1016/j.canlet.2022.215837. Epub 2022 Jul 31. PubMed |
Identification and functional comparison of novel alternatively spliced isoforms of human YAP. Liu L, Zhang J, Wang J, Tian Y, Wang J, Xu Y, Cheng Y, Yu M, Wang J, Yang Y, Wang X, Yang R, Wu W, Zhang C, Hu Y, Jian R, Xiao L, Ruan Y. FEBS Open Bio. 2023 Jun;13(6):1001-1014. doi: 10.1002/2211-5463.13618. Epub 2023 May 8. PubMed |
Yes-associated protein nuclear translocation promotes anabolic activity in human articular chondrocytes. Cui Y, Miao MZ, Wang M, Su QP, Qiu K, Arbeeva L, Chubinskaya S, Diekman BO, Loeser RF. Osteoarthritis Cartilage. 2023 Aug;31(8):1078-1090. doi: 10.1016/j.joca.2023.04.006. Epub 2023 Apr 24. PubMed |
RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer. Prokakis E, Jansari S, Boshnakovska A, Wiese M, Kusch K, Kramm C, Dullin C, Rehling P, Glatzel M, Pantel K, Wikman H, Johnsen SA, Gallwas J, Wegwitz F. Cell Death Dis. 2023 Sep 28;14(9):641. doi: 10.1038/s41419-023-06157-5. PubMed |
Sirtuin 5-mediated deacetylation of TAZ at K54 promotes melanoma development. Kim G, Bhattarai PY, Lim SC, Lee KY, Choi HS. Cell Oncol (Dordr). 2023 Dec 19. doi: 10.1007/s13402-023-00910-w. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.